Alecia Mitchell

Alecia Mitchell serves as the primary Point of Contact for the University of South Carolina, overseeing the procurement of specialized electromedical and electrotherapeutic equipment critical to the institution’s research, clinical, and instructional missions. In this role, she manages the full lifecycle of acquisitions—from requirements definition and market research to contract award and performance monitoring—ensuring alignment with institutional priorities in advancing scientific innovation and campus health services. Her work directly supports the deployment of advanced diagnostic, therapeutic, and rehabilitative technologies across university-affiliated laboratories, medical training facilities, and patient care environments. While no specific contractor relationships are currently documented in the procurement record, Mitchell engages with a broad spectrum of vendors specializing in FDA-regulated medical devices, clinical monitoring systems, and precision therapeutic equipment. She collaborates with manufacturers, authorized distributors, and systems integrators to secure technically compliant, interoperable solutions that meet stringent institutional and regulatory standards. Her procurement approach emphasizes vendor responsiveness, technical documentation rigor, and post-award support capabilities. Mitchell’s contracting activity is entirely non-set-aside, with 100% of acquisitions conducted under standard competitive procedures without socioeconomic preferences. This reflects the University’s operational need for specialized, high-precision equipment where qualified suppliers are limited and technical specifications demand exacting compliance. While small business participation is not formally incentivized in her portfolio, all solicitations adhere to full and open competition requirements under FAR Part 6. Her primary focus is on NAICS 334510, encompassing the procurement of electromedical devices such as electrotherapy units, nerve stimulators, diagnostic imaging peripherals, and rehabilitation robotics. She possesses deep expertise in evaluating technical specifications, clinical validation data, and FDA classification pathways, ensuring acquisitions support both cutting-edge research and accredited clinical training programs.